Department of Public Health and Sports Sciences, Faculty of Health and Life Sciences, University of Exeter, Heavitree Road, Exeter, EX1 2LU, UK.
Academic Department of Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, Barrack Road, Exeter, EX2 5DW, UK.
BMC Pulm Med. 2022 Dec 22;22(1):485. doi: 10.1186/s12890-022-02289-0.
Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to be fully characterised, and this study fills this evidence gap.
Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month window. Technical standards from the European Respiratory Society established validity, and repeatability was determined using mean change, intraclass correlation coefficient and typical error.
Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO, the primary criteria for establishing a maximal effort. The majority of participants otherwise presented with secondary criteria of respiratory exchange ratios in excess of 1.05, and maximal heart rates in excess of their predicted values. Repeatability analyses identified that the typical error (expressed as percent of coefficient of variation) was 20% over 3-months in those reaching volitional exhaustion.
This work has, for the first time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verification criteria, and generated novel repeatability data that will prove useful in the assessment of disease progression, and future evaluation of therapeutic regimens where VO is used as an outcome measure.
心肺运动测试(CPET)及其主要结果峰值摄氧量(VO)已被公认为间质性肺病(ILD)诊断和预后管理的生物标志物。然而,ILD 患者的 CPET 的有效性和可重复性尚未得到充分描述,本研究填补了这一证据空白。
招募了 26 名ILD 患者,其中 21 名成功完成了 3 次 CPET。其中,17 名在 3 个月的窗口期内完成了两次有效的 CPET,11 名在 6 个月的窗口期内完成了两次有效的 CPET。欧洲呼吸学会的技术标准确立了有效性,使用平均变化、组内相关系数和典型误差来确定可重复性。
每一位成功进行到意愿性疲劳的参与者(100%)都产生了最大的、因此也是有效的 CPET。大约 20%的参与者出现了 VO 平台,这是建立最大努力的主要标准。大多数参与者的其他标准是呼吸交换比超过 1.05,以及最大心率超过其预测值。重复性分析表明,在达到意愿性疲劳的参与者中,3 个月内的典型误差(表示为变异系数的百分比)为 20%。
这项工作首次全面描述了 ILD 患者在主要和次要验证标准方面对 CPET 的反应,并生成了新的可重复性数据,这将有助于评估疾病进展,并在未来评估将 VO 作为结果测量的治疗方案。